Raloxifene 60 mg

Dragon Pharma Raloxifene 60 mg – Tissue-Selective Estrogen Receptor Modulator

Dragon Pharma Raloxifene 60 mg is a high-purity formulation of Raloxifene Hydrochloride, a second-generation selective estrogen receptor modulator (SERM) belonging to the benzothiophene class of compounds. Raloxifene functions by competitively binding to estrogen receptors (ERα and ERβ) with high affinity, exhibiting unique tissue-selective pharmacology. In bone and lipid metabolism, it acts as an estrogen agonist; in breast and uterine tissue, it functions as an antagonist. This distinct profile provides researchers with a refined SERM tool for studying tissue-specific estrogen signaling, distinguishing it from triphenylethylene SERMs like tamoxifen and toremifene.

If your laboratory requires reliable Dragon Pharma Raloxifene for endocrine or tissue-selective ER research, this 100-tablet sachet delivers 6000 mg total compound with dual third-party verified potency reports from Analiza Bialek and Janoshik. For researchers studying tissue-specific estrogen modulation, bone metabolism, or comparative SERM pharmacology, finding legit Raloxifene from a verified source ensures reproducible, consistent data.

Why Athletes & Bodybuilders Are Researching Raloxifene

Estrogen receptor modulation with tissue selectivity is an important consideration in endocrine research. Raloxifene research explores its unique tissue-specific effects, including estrogen antagonism in breast tissue while maintaining favorable effects on lipid profiles in research models. For researchers examining SERM-specific ER pathways, comparative SERM pharmacology, or tissue-selective estrogen modulation without uterine stimulation, Raloxifene provides a distinct alternative to other SERMs with a unique benzothiophene structure and tissue-specific activity profile.

What Makes Dragon Pharma Raloxifene 60 mg Different?

• ✔ Benzothiophene SERM class – distinct from triphenylethylene agents
• ✔ Tissue-selective pharmacology – agonist in bone/lipids, antagonist in breast/uterus
• ✔ 60 mg tablet format for standardized tissue-selective SERM research protocols
• ✔ Dual third-party lab verified by Analiza Bialek (58.23 mg) and Janoshik (54.15 mg) – batch #HD9TX23

Note for researchers: Raloxifene is a unique tissue-selective SERM with distinct pharmacology from tamoxifen. For best results in tissue-specific ER research, follow established protocols and always source legit Raloxifene from Dragon Pharma.

Product Specifications

Dosage & Research Guidelines

Research Dosing Guidelines

Based on available research literature, typical Raloxifene dosing in rodent models falls within this range:

• ✔ 1 – 10 mg per kg in research models (dose-dependent tissue-selective effects)
• ✔ One 60 mg tablet provides a potent oral research dose for larger models
• ✔ One 100-tablet sachet provides 6000 mg total compound for extended protocols
• ✔ Research protocols typically run 8-12 weeks for tissue-specific ER studies

Tablet Dosing Guide

For research involving precise oral administration of Raloxifene 60 mg tablets:

• ✔ Whole tablet = 60 mg dose
• ✔ Half tablet = 30 mg dose (use calibrated tablet splitter)
• ✔ Quarter tablet = 15 mg dose (for lower dose protocols)
• ✔ Once daily administration standard for SERM research protocols

How Researchers Are Using Raloxifene

Raloxifene is the prototypical benzothiophene SERM, distinguished by its tissue-selective agonist/antagonist profile and lack of uterine stimulation, making it valuable for studying tissue-specific estrogen receptor signaling.

Popular research stacks and comparisons include:

• ✔ Raloxifene + Tamoxifen — for comparative benzothiophene vs triphenylethylene SERM research
• ✔ Raloxifene + Toremifene — for comparative SERM tissue selectivity studies. View Toremfine →
• ✔ Raloxifene + Clomid — for comparative SERM pharmacology research. View Clomid →

Research Protocol Example (10 Weeks)

• ✔ Weeks 1-10: Raloxifene 15-30 mg once daily oral
• ✔ Lower doses (15 mg) for tissue-selective modulation; higher (30-60 mg) for complete ER antagonism in target tissues
• ✔ Washout period: 10-14 days observation post-protocol (long half-life)

Important Considerations

• 🔬 Raloxifene is a benzothiophene SERM with unique tissue-selective pharmacology
• 💊 Oral administration with once daily dosing provides sustained ER modulation
• ⚠️ Research suggests estrogen agonist effects on bone/lipids, antagonist effects on breast/uterus
• 📦 Store tablets in original sachet with desiccant to prevent degradation
• 📦 Always source Dragon Pharma Raloxifene from verified suppliers for research integrity

Lab Verification – Third-Party Test Results

At Dragon Pharma, every batch of research compounds undergoes independent third-party HPLC testing to verify dosage, purity, and identity. Below are multiple test results for Dragon Pharma Raloxifene 60 mg (Batch #HD9TX23), analyzed by Analiza Bialek and Janoshik.

Lab file

raloxifene-lab-test-2025-04-18

Test Date

2025-04-18

Batch Number

#HD9TX23

Measured Result

58.23 mg

Assay vs Label

97.05%

COA summary: Dosage verified within specification. Purity and identity confirmed.

Latest Batch - Analiza Bialek

Previous Batch Report (Same Batch #HD9TX23)

Lab file

raloxifene-lab-test-2024-01-04

Test Date

2024-01-04

Batch Number

#HD9TX23

Measured Result

54.15 mg

Assay vs Label

90.25%

COA summary: Dosage verified within specification. Purity and identity confirmed.

Previous - Janoshik

Why Third-Party Testing Matters

With the proliferation of unverified research chemicals, independent lab analysis is the only method to confirm compound identity and purity. Legit Raloxifene should meet strict quality specifications. Dragon Pharma commits to full transparency — dual batch-specific COAs from Analiza Bialek and Janoshik are published here, demonstrating our commitment to quality consistency.

For more information on Raloxifene research and SERM biology, refer to this PubMed study on raloxifene pharmacology.

Shipping & Product Authenticity

What to Expect

• ✔ Orders processed within 24–48 hours after payment confirmation
• ✔ USA Domestic shipping via USPS/UPS/FedEx — tracking included
• ✔ International tracking available (update frequency varies by destination)
• ✔ Sachets are shipped in protective packaging with desiccant

How to Verify You Have Legit Raloxifene

Counterfeit research compounds are a genuine concern. Here's how to confirm you're receiving authentic Dragon Pharma Raloxifene:

• ✔ QR code verification — each package includes a unique QR code. Scan to verify batch on Dragon Pharma's official database
• ✔ Scratch-off serial number — reveals a one-time use code for online verification
• ✔ Batch traceability — match the batch number (#HD9TX23) to our dual lab test results above
• ✔ Original sealed sachet — intact, tamper-evident foil packaging

For complete delivery details, tracking policy, international customs, and reshipment terms, please see our Shipping Info page.

Storage Guidelines

Storage Recommendations

• ✔ Store at 15–25°C (59–77°F) — controlled room temperature
• ✔ Keep in original sachet with desiccant until first use
• ✔ Protect from moisture, humidity, and direct light
• ✔ Keep away from heat sources
• ✔ Stable for up to 24 months when stored properly in sealed sachet

What to Avoid

• ❌ High humidity or moisture — can degrade tablet integrity
• ❌ Leaving sachet open after first use — reseal or store in airtight container
• ❌ Extreme temperatures (>30°C or <0°C)
• ❌ Storing in bathroom or near heat sources
• ❌ Using tablets that show discoloration, spots, or crumbling

Inspection Before Use

Before using Raloxifene 60 mg tablets in your research, always inspect the product:

• ✔ Tablets should be intact, uniform in color and shape
• ✔ Sachet seal must be intact — do not use if seal is broken or shows tampering
• ✔ Check batch number and QR code for authenticity before use

Keep out of reach of children and unauthorized personnel. Follow institutional laboratory safety guidelines for handling research compounds.

Frequently Asked Questions